EPO’s new examination guidelines: what you need to know

A new edition of the European Patent Office (EPO) Guidelines for Examination came into force on March 1, 2021. Relevant to life sciences, this edition includes a new subsection detailing EPO practice with respect to the interpretation of terms relating to amino or nucleic acid sequences, as well as a new section on the examination of claims to antibodies.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Pharma patent filings rise at EPO amid pandemic

5 April 2022 Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.

Europe

EPO Enlarged Board of Appeal issues G 2/21 decision

28 March 2023 Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

Europe

EPO launches Unitary Patent dashboard revealing daily take-up figures

25 July 2023 Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.

More on this story

Europe

Pharma patent filings rise at EPO amid pandemic

5 April 2022 Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.

Europe

EPO Enlarged Board of Appeal issues G 2/21 decision

28 March 2023 Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

Europe

EPO launches Unitary Patent dashboard revealing daily take-up figures

25 July 2023 Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.

More on this story

Europe

Pharma patent filings rise at EPO amid pandemic

5 April 2022 Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.

Europe

EPO Enlarged Board of Appeal issues G 2/21 decision

28 March 2023 Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

Europe

EPO launches Unitary Patent dashboard revealing daily take-up figures

25 July 2023 Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

CRISPR patents revoked following Nobel Prize winners’ withdrawal

White & Case hires experienced litigator from A&O Shearman

EPO’s new examination guidelines: what you need to know

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features